Thus, reduction of FAK activity by a FAK inhibitor is proved to modulate the expression of miR-18a followed by lowing PTEN expression and elevating PI3K/AKT signaling in promoting tumor invasion and metastasis [87]. Here, PTK2 is linked to neoplasm.